{"nct_id":"NCT04812925","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients with Primary Immune Thrombocytopenia","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-12","start_date":"2021-11-17","start_date_type":"ACTUAL","primary_completion_date":"2026-10-01","primary_completion_date_type":"ESTIMATED","completion_date":"2026-10-01","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["ARGX"]}